3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Cardiogenic Shock: new trials by email Literature Review of Cardiogenic Shock trials Research Report on Cardiogenic Shock
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock Istaroxime, Placebo - Cardiogenic Shock | Phase 2 | Completed | Windtree Therapeutics | 90 | 2020-09-28 | 2025-02-04 |
| Adrecizumab in Cardiogenic Shock Adrecizumab, Placebo - Cardiogenic Shock, Endothelial Dysfunction | Phase 2 / Phase 3 | Completed | Dr. med. Mahir Karakas | 150 | 2019-04-04 | 2021-10-08 |
| Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock adrenaline - Cardiogenic Shock | Phase 2 | Completed | Niguarda Hospital | 24 | 2015-10-01 | 2021-07-26 |
Shock, Cardiogenic (3) · Heart Failure (1)
Cardiovascular Diseases (3) · Heart Diseases (3) · Infarction (3) · Ischemia (3) · Myocardial Infarction (3) · Myocardial Ischemia (3) · Necrosis (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Shock (3) · Vascular Diseases (3)
Epinephrine (1) · Istaroxime (1) · Sodium Chloride (1) · enibarcimab (1)
Dr. med. Mahir Karakas (1) · Niguarda Hospital (1) · Windtree Therapeutics (1)
Italy (2) · Argentina (1) · Germany (1) · Poland (1) · United States (1)
Mahir Karakas, MD, MBA (1) · Marco Metra, MD (1)